Skip to main content
    H

    Humana Inc (HUM)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $432.13
    +4.73 (+1.11%)

    Market Cap: $51.32B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(37/39)
    Avg Surprise
    +5.66%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.00
    Range$-1.16 - $-0.60
    23 analysts
    EPS RevisionsNo revisions (7d)
    1
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.17-491.7%
    60d ago$-1.02+1.1%
    30d ago$-0.94-7.0%
    7d ago$-1.00-0.1%
    Current$-1.00
    Revenue Consensus
    $40.9B
    Range$40.4B - $41.4B
    17 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-7.03
    Range$-7.74 - $-5.64
    26 analysts
    Revenue Consensus
    $41.9B
    Range$40.7B - $44.1B
    21 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-7.03---
    Sep 26EST
    		-$-1.00---
    Jun 26
    Reported Jul 29
    		$7.61$6.22+22.35%Beat+21.4%
    Mar 26
    Reported Apr 29
    		$10.31$10.20+1.08%Beat-11.0%
    Dec 25
    Reported Feb 11
    		$-3.96$-3.99+0.75%Beat-83.3%
    Sep 25
    Reported Nov 5
    		$3.24$2.91+11.34%Beat-22.1%
    Jun 25
    Reported Jul 30
    		$6.27$5.87+6.81%Beat-9.9%
    Mar 25
    Reported Apr 30
    		$11.58$10.07+14.99%Beat+60.2%
    Dec 24
    Reported Feb 11
    		$-2.16$-2.12-1.89%Miss-1863.6%
    Sep 24
    Reported Oct 30
    		$4.16$3.39+22.71%Beat-46.5%
    Jun 24
    Reported Jul 31
    		$6.96$5.86+18.77%Beat-22.1%
    Mar 24
    Reported Apr 24
    		$7.23$6.00+20.50%Beat-22.9%
    Dec 23
    Reported Jan 25
    		$-0.11N/A-111.96%Miss-106.8%
    Sep 23
    Reported Nov 1
    		$7.78$7.17+8.51%Beat+13.1%
    Jun 23
    Reported Aug 2
    		$8.94$8.83+1.25%Beat+3.1%
    Mar 23
    Reported Apr 26
    		$9.38$9.20+1.96%Beat+16.7%
    Dec 22
    Reported Feb 1
    		$1.62$1.46+10.96%Beat+30.6%
    Sep 22
    Reported Nov 2
    		$6.88$6.28+9.55%Beat+42.4%
    Jun 22
    Reported Jul 27
    		$8.67$7.67+13.04%Beat+25.8%
    Mar 22
    Reported Apr 27
    		$8.04$6.80+18.24%Beat+4.8%
    Dec 21
    Reported Feb 2
    		$1.24$1.16+6.90%Beat+153.9%
    Sep 21
    Reported Nov 3
    		$4.83$4.67+3.43%Beat+56.8%
    Jun 21
    Reported Jul 28
    		$6.89$6.84+0.73%Beat-45.1%
    Mar 21
    Reported Apr 28
    		$7.67$7.10+8.03%Beat+42.0%
    Dec 20
    Reported Feb 3
    		$-2.30$-2.32+0.86%Beat-200.9%
    Sep 20
    Reported Nov 3
    		$3.08$2.80+10.00%Beat-38.8%
    Jun 20
    Reported Aug 5
    		$12.56$10.12+24.11%Beat+107.6%
    Mar 20
    Reported Apr 29
    		$5.40$4.69+15.14%Beat+20.5%
    Dec 19
    Reported Feb 5
    		$2.28$2.19+4.11%Beat-14.0%
    Sep 19
    Reported Nov 6
    		$5.03$4.57+10.07%Beat+9.8%
    Jun 19
    Reported Jul 31
    		$6.05$5.27+14.80%Beat+52.8%
    Mar 19
    Reported May 1
    		$4.48$4.30+4.19%Beat+33.3%
    Dec 18
    Reported Feb 6
    		$2.65$2.53+4.74%Beat+28.6%
    Sep 18
    Reported Nov 7
    		$4.58$4.24+8.02%Beat+35.1%
    Jun 18
    Reported Aug 1
    		$3.96$3.78+4.76%Beat+13.5%
    Mar 18
    Reported May 2
    		$3.36$3.20+5.00%Beat+22.2%
    Dec 17
    Reported Feb 7
    		$2.06$2.00+3.00%Beat-1.4%
    Sep 17
    Reported Nov 8
    		$3.39$3.27+3.67%Beat-
    Jun 17
    Reported Aug 2
    		$3.49$3.06+14.05%Beat-
    Mar 17
    Reported May 3
    		$2.75$2.63+4.56%Beat-
    Dec 16
    Reported Feb 8
    		$2.09$2.06+1.46%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.82%
    Forward Annual Dividend$3.54
    Payout Ratio12.56%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct, Nov

    Growth

    3Y CAGR+3.97%
    5Y CAGR+7.20%
    HUM dividend history and ex-dividend datesRun HUM in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio25.12EV/EBITDA18.78x
    Price/FCF26.62xFCF Yield3.76%
    Profitability
    Profit Margin0.88%Operating Margin3.46%
    ROE6.89%ROIC5.83%
    Financial Health
    Debt/Equity0.74xInterest Coverage3.37x
    Current Ratio1.74xQuick Ratio1.74x
    Trading Statistics
    Beta0.74Avg Volume1.55M
    52-Week High$456.5052-Week Low$161.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$412.56
    SMA 20$397.66
    SMA 50$393.00
    SMA 200$299.62
    EMA 10$415.25
    EMA 20$405.64
    EMA 50$393.02
    EMA 200$330.71

    MACD

    Line: 10.11Signal: 5.65Hist: 4.47

    ADX

    ADX: 23.8+DI: 32.3-DI: 17.8

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down36.0
    PSAR$382.12

    Bollinger Bands

    Upper Band$438.87
    Lower Band$356.45
    %B Position2073%(Upper)
    Band Width0.92

    RSI (14-Day)

    Neutral
    63.5

    Momentum Oscillators

    Stoch %K63.6
    Stoch %D65.4
    Williams %R-30.2
    ROC (10d)13.8%
    Momentum52.45
    CCI (20d)134.9
    MFI (14d)46.8

    Volatility Measures

    ATR (14d)$18.21(4.2%)
    StdDev (20d)20.61
    Hist Vol52.5%(High)

    Volume Flow

    VWAP$433.09
    OBV67.0M
    AD Line-327.5M
    CMF (20d)-0.184

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio0.6x
    VWMA (20d)$402.86

    Pivot Points

    R3$443.04
    R2$437.59
    R1$432.50
    Pivot Point$427.05
    S1$421.96
    S2$416.51
    S3$411.42

    Advanced Oscillators

    TSI18.47
    Ultimate Osc49.4
    KST48.95

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$40.87B$39.65B$32.52B$32.65B$32.39B$32.11B$29.21B$29.40B$29.54B$29.61B$26.46B$26.42B
    Cost of Revenue$35.37B$33.71B$28.72B$27.99B$27.57B$26.54B$25.38B$25.12B$25.04B$25.12B$22.78B$21.75B
    Gross Profit$5.50B$5.94B$3.79B$4.66B$4.82B$5.58B$3.83B$4.28B$4.50B$4.49B$3.68B$4.68B
    Operating Expenses$4.14B$4.19B$4.60B$4.26B$3.73B$3.56B$4.38B$3.55B$3.36B$3.25B$4.03B$3.47B
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$3.98B$4.02B$4.44B$4.08B$3.55B$3.38B$4.17B$3.34B$3.15B$3.04B$3.83B$3.27B
    Operating Income$1.36B$1.75B$-808,000,000$400.00M$1.10B$2.01B$-543,000,000$728.00M$1.14B$1.24B$-348,000,000$1.21B
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$197.00M$193.00M$146.00M$168.00M$157.00M$160.00M$164.00M$169.00M$168.00M$159.00M$146.00M$114.00M
    Income Before Tax$952.00M$1.59B$-1,011,000,000$134.00M$741.00M$1.69B$-862,000,000$651.00M$918.00M$1.01B$-591,000,000$1.10B
    Income Tax Expense$238.00M$395.00M$-249,000,000$-86,000,000$179.00M$406.00M$-216,000,000$155.00M$223.00M$251.00M$-75,000,000$256.00M
    Net Income$693.00M$1.18B$-776,000,000$194.00M$543.00M$1.24B$-683,000,000$480.00M$678.00M$739.00M$-540,000,000$830.00M
    EBITDA$1.34B$1.98B$-671,000,000$506.00M$1.11B$2.07B$-458,000,000$1.06B$1.33B$1.42B$-207,000,000$1.45B
    EBIT$1.15B$1.79B$-865,000,000$302.00M$898.00M$1.85B$-698,000,000$820.00M$1.09B$1.17B$-445,000,000$1.21B
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    I Tested One Of Wall Street’s Favorite AI Trades - It Failed

    Travelers Q2 core income $10.04 vs $5.41 consensus, stock +10%; CEO credited AI for a 0.5 percentage-point improvement in underlying loss ratio while expense ratio rose to 29%. Wall Street thesis posits AI cuts SG&A to create EPS torque in low-margin giants - e.g....

    Leo Nelissen
    •
    8/2/26
    •
    248
    AI Stocks
    Also mentions:
    TRVCVSKRWMTUNH

    Health Insurer Stocks: Recent Crash is Likely An Attractive Buffett Style "Fat Pitch" Opportunity

    Monday Jan 27th was "The Monday night massacre" when Medicare announced a 0.7% increase in reimbursement rates for 2026. 5% to 6% was the consensus and health insurance companies fell between 8% and 20% in overnight trading. Only Humana has continued to decline (-26% so far) but Morningstar (and I)...

    Adam Galas
    •
    1/29/26
    •
    324
    value investing, Income, Value, Dividend Growth, Dividend Investing
    Also mentions:
    ELVCVSHUM

    3 Ways Your Family Can Thrive In The Age Of AI

    The Age of AI is simultaneously terrifying, thrilling, terrible, delightful, and full of wonders. To keep your family safe, sane, and prosperous requires a humble appreciation that the world is more complex than any human can imagine...

    Adam Galas
    •
    11/13/25
    •
    541
    economy, earnings, recession, Dividend Investing
    Also mentions:
    HUMBAM

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -100.0%
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Elevance Health stock: Guggenheim lifts target to USD 460 for Elevance Health stock

    Guggenheim has raised its price target for Elevance Health (ELV) stock to $460 from $455, maintaining a Buy rating. The stock's current market price is near its 52-week high...

    ad-hoc-news.de•10/16/26•Neutral

    Form 144 WILLIAMS SONOMA INC Filed by: Finucane Anne A.

    Anne A. Finucane, a director at Williams-Sonoma, Inc., has filed a Form 144 to sell 794 shares of common stock with an aggregate market value of $200,195.92. The securities were acquired on May 31, 2023...

    StreetInsider•10/16/26•Neutral

    Form SC TO-T/A ACV Auctions Inc. Filed by: COPART INC

    Copart Inc.'s subsidiary, Apple Merger Sub, Inc., has completed its tender offer for ACV Auctions Inc. All tendered shares have been accepted, and the merger was effected under Section 251(h) of the DGCL...

    StreetInsider•10/16/26•Neutral

    Li Auto raises RMB1.625 billion for chip subsidiary MHX Technology

    Li Auto Inc. announced that its chip and domain controller subsidiary, MHX Technology, has secured RMB1.625 billion in equity financing. Li Auto will contribute RMB1.0 billion...

    StreetInsider•10/16/26•Neutral

    Triasima Portfolio Management inc. Acquires New Stake in Healthcare Services Group, Inc. $HCSG

    Triasima Portfolio Management inc. has acquired a new stake in Healthcare Services Group, Inc. (NASDAQ:HCSG), purchasing 61,590 shares valued at approximately $1.26 million. This acquisition represents about 0.09%...

    MarketBeat•10/16/26•Neutral

    HUM Valuation and Fair Value

    P/E
    25.1x
    Forward P/E
    24.3x
    EV/EBITDA
    18.8x
    P/FCF
    26.6x
    PEG
    1.3x
    P/B
    2.7x
    See GNG's fair value

    HUM Profitability: Margins, ROIC and FCF

    Gross margin
    13.7%
    Operating margin
    3.5%
    Net margin
    0.9%
    ROIC
    5.8%
    ROE
    6.9%
    FCF margin
    1.3%
    FCF yield
    3.8%

    HUM Competitors

    CompanyTicker
    Becton Dickinson and CompanyBDX
    argenx NV ADRARGX
    Natera IncNTRA
    Edwards Lifesciences CorpEW
    Cardinal Health IncCAH
    Agilent Technologies IncA
    Takeda Pharmaceutical Co Ltd ADRTAK
    Veeva Systems Inc Class AVEEV

    Sector: Healthcare

    HUM Analyst Ratings

    Consensus
    Buy
    Analysts
    26
    Strong Buy
    2
    Buy
    11
    Hold
    12
    Sell
    1
    Strong Sell
    0

    HUM Bull Case vs Bear Case

    Bull case

    • HUM beat EPS estimates in 87.5% of its last 8 reported quarters.
    • HUM grew quarterly revenue 26.2% year over year.

    HUM Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    9.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.00
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 3 down

    HUM Dividend

    Forward yield
    0.8%
    Payout ratio
    12.6%
    3Y DPS growth
    4.0%
    5Y DPS growth
    7.2%
    Pay months
    Jan, Apr, Jul, Oct, Nov
    HUM dividend history

    Frequently Asked Questions About HUM

    What is HUM's current dividend yield?

    Humana Inc (HUM) has a forward dividend yield of 0.82%.

    Does HUM pay dividends?

    Yes, Humana Inc pays dividends with a forward dividend yield of 0.82%.

    What is HUM's P/E ratio?

    Humana Inc has a price-to-earnings (P/E) ratio of 25.12.

    What is HUM's market cap?

    Humana Inc (HUM) has a market capitalization of $51.32B with a current stock price of $432.13.

    Related stocks

    Sector: Healthcare

    All stocks starting with H

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In